|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002475,
umls-concept:C0013216,
umls-concept:C0016360,
umls-concept:C0040808,
umls-concept:C0069717,
umls-concept:C0123931,
umls-concept:C0205195,
umls-concept:C0282460,
umls-concept:C0332257,
umls-concept:C0677667,
umls-concept:C1527249
|
|
pubmed:issue |
3C
|
|
pubmed:dateCreated |
2003-8-20
|
|
pubmed:abstractText |
To investigate the therapeutic value and safety of a third-line treatment with raltitrexed and mitomycin-C (MMC) in patients with advanced colorectal cancer (ACC) pretreated with combination regimens including 5-fluorouracil (5-FU), irinotecan (CPT-11) and oxaliplatin (L-OHP).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2981-5
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12926149-Aged,
pubmed-meshheading:12926149-Aged, 80 and over,
pubmed-meshheading:12926149-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12926149-Camptothecin,
pubmed-meshheading:12926149-Colorectal Neoplasms,
pubmed-meshheading:12926149-Drug Administration Schedule,
pubmed-meshheading:12926149-Female,
pubmed-meshheading:12926149-Fluorouracil,
pubmed-meshheading:12926149-Humans,
pubmed-meshheading:12926149-Male,
pubmed-meshheading:12926149-Middle Aged,
pubmed-meshheading:12926149-Mitomycin,
pubmed-meshheading:12926149-Organoplatinum Compounds,
pubmed-meshheading:12926149-Prospective Studies,
pubmed-meshheading:12926149-Quinazolines,
pubmed-meshheading:12926149-Thiophenes
|
|
pubmed:articleTitle |
Raltitrexed and mitomycin-C as third-line chemotherapy for colorectal cancer after combination regimens including 5-fluorouracil, irinotecan and oxaliplatin: a phase II study.
|
|
pubmed:affiliation |
Medical Oncology Unit, S. Carlo Hospital, Potenza, Italy. rosatiger@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
